Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional Anesthesia in Hip Arthroscopy
NCT02851888Phase 4Unknown
- Sponsor
- Georgetown University
- Start
- Jul 2016
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in Femoroacetabular impingement (FAI) and Hip injury (2 arms), sponsored by Georgetown University. Primary endpoint: Pain Medication Requirement in PACU. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
Femoroacetabular impingement (FAI)Hip injury
Beyond the preview
Go deeper on NCT02851888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02851888.